Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
53.31
-1.54 (-2.81%)
Aug 10, 2026, 10:31 AM EDT - Market open
PBH Revenue
Prestige Consumer Healthcare had revenue of $265.71M in the quarter ending June 30, 2026, with 6.48% growth. This brings the company's revenue in the last twelve months to $1.10B, down -1.36% year-over-year. In the fiscal year ending March 31, 2026, Prestige Consumer Healthcare had annual revenue of $1.09B, down -4.31%.
Revenue (ttm)
$1.10B
Revenue Growth
-1.36%
P/S Ratio
2.31
Revenue / Employee
$1,241,444
Employees
890
Market Cap
2.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.09B | -49.06M | -4.31% |
| Mar 31, 2025 | 1.14B | 12.41M | 1.10% |
| Mar 31, 2024 | 1.13B | -2.37M | -0.21% |
| Mar 31, 2023 | 1.13B | 40.91M | 3.76% |
| Mar 31, 2022 | 1.09B | 143.45M | 15.21% |
| Mar 31, 2021 | 943.37M | -19.65M | -2.04% |
| Mar 31, 2020 | 963.01M | -12.77M | -1.31% |
| Mar 31, 2019 | 975.78M | -65.40M | -6.28% |
| Mar 31, 2018 | 1.04B | 159.12M | 18.04% |
| Mar 31, 2017 | 882.06M | 75.81M | 9.40% |
| Mar 31, 2016 | 806.25M | 91.62M | 12.82% |
| Mar 31, 2015 | 714.62M | 117.24M | 19.63% |
| Mar 31, 2014 | 597.38M | -22.74M | -3.67% |
| Mar 31, 2013 | 620.12M | 179.03M | 40.59% |
| Mar 31, 2012 | 441.09M | 104.58M | 31.08% |
| Mar 31, 2011 | 336.51M | 43.91M | 15.01% |
| Mar 31, 2010 | 292.60M | -1.74M | -0.59% |
| Mar 31, 2009 | 294.35M | -20.76M | -6.59% |
| Mar 31, 2008 | 315.11M | -3.53M | -1.11% |
| Mar 31, 2007 | 318.63M | 21.97M | 7.40% |
| Mar 31, 2006 | 296.67M | 7.60M | 2.63% |
| Mar 31, 2005 | 289.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.85B |
| Perrigo Company | 4.14B |
| Indivior Pharmaceuticals | 1.33B |
| Trulieve Cannabis | 1.17B |
| ANI Pharmaceuticals | 978.38M |
| BioCryst Pharmaceuticals | 940.61M |
| Supernus Pharmaceuticals | 830.44M |
| HUTCHMED (China) | 549.12M |
PBH News
- 4 days ago - Prestige Consumer Healthcare Earnings Call Transcript: Q1 2027 - Transcripts
- 4 days ago - Prestige Consumer Healthcare Earnings release: Q1 2027 - Filings
- 4 days ago - Prestige Consumer Healthcare Quarterly report: Q1 2027 - Filings
- 4 days ago - Prestige Consumer Healthcare Slides: Q1 2027 - Filings
- 4 days ago - Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results - GlobeNewsWire
- 5 weeks ago - Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date - GlobeNewsWire
- 5 weeks ago - Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes - GlobeNewsWire
- 6 weeks ago - Prestige Consumer Healthcare Proxy statement: Proxy filing - Filings